Phase II study of de-intensification of radiation and chemotherapy for low-risk HPV-related oropharyngeal squamous cell carcinoma.

Bhishamjit S. Chera,Bahjat F. Qaqish,Mark C. Weissler,David N. Hayes,Carol G. Shores,Alan T. Monroe,Roger F. Anderson,Justin Wu,Juneko E. Grilley-Olson,Jared Weiss,Trevor Hackman,Adam M. Zanation,William M. Mendenhall,Robert J. Amdur

Phase II study of de-intensification of radiation and chemotherapy for low-risk HPV-related oropharyngeal squamous cell carcinoma.

2017

Bhishamjit S. Chera
Bahjat F. Qaqish
Mark C. Weissler
David N. Hayes
Carol G. Shores
Alan T. Monroe
Roger F. Anderson
Justin Wu
Juneko E. Grilley-Olson
Jared Weiss
Trevor Hackman
Adam M. Zanation
William M. Mendenhall
Robert J. Amdur

TPS6097 Background: The prognosis is excellent for low-risk human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma (OPSCC). Current standard chemoradiotherapy (CRT) regimens cu...

Keywords:

Pathology
Oncology
Phases of clinical research
Internal medicine
Oropharyngeal squamous cell carcinoma
Medicine
Chemoradiotherapy
Chemotherapy
human papillomavirus

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations